<?xml version="1.0" encoding="UTF-8"?>
<p id="p0445">Several studies of novel influenza therapeutics are under investigation, including the NAIs IV zanamivir and laninamivir, monoclonal antibodies, viral polymerase inhibitors, and nitazoxanide. The performance and safety of these newer agents remain to be seen in immunocompromised children. </p>
